Network Director Ed Harding will present a case study on sustainability and resilience in heart failure at the PHSSR global summit on 16 March

News & Events

5 March 2021

The Partnership for Health System Sustainability and Resilience (PHSSR), established by the World Economic Forum, the London School of Economics and AstraZeneca, will host its inaugural Virtual Global Summit on 15–16 March. The summit will bring together the academic, public and private sectors to share insights on improving health system sustainability and resilience. It will draw on lessons learnt from the COVID-19 pandemic and contribute to the discussions on long-term safeguarding and improvement of global health.

In a session entitled ‘Improving the effectiveness of care’, HFPN Network Director Ed Harding will present key findings and recommendations from a European case study on preventing hospital admissions in heart failure. The case study focuses on building resilience in five health system domains: governance, financing, service delivery, workforce, and medications and technology. It will be published on the PHSSR website ahead of the event, alongside case studies on lung cancer, chronic kidney disease, chronic airways disease, and digital and artificial intelligence.

To take part in the session, you need to register for the event. The session will be held between 12:00 and 13:15 (GMT) on Tuesday, 16 March. Other confirmed speakers include Professor Fausto Pinto, President-Elect of the World Heart Federation and Suzanne Wait, Managing Director of The Health Policy Partnership.


More from News & Events

Five lessons from the European Heart Failure Mission launch
Five lessons from the European Heart Failure Mission launch ...
15 November 2023
In October 2023, the HFPN launched the European Heart Failure Mission Statement at the European Parliament. Here's five things we learned....
Read article
HFPN identifies six priority areas for future EU research in
HFPN identifies six priority areas for future EU research in...
27 October 2023
The HFPN has outlined six area which EU funding programmes should direct investments in heart failure research....
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .